RGEN
Repligen Corp
Price:  
149.06 
USD
Volume:  
1,176,792.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN WACC - Weighted Average Cost of Capital

The WACC of Repligen Corp (RGEN) is 8.0%.

The Cost of Equity of Repligen Corp (RGEN) is 8.30%.
The Cost of Debt of Repligen Corp (RGEN) is 4.45%.

Range Selected
Cost of equity 7.10% - 9.50% 8.30%
Tax rate 11.30% - 15.70% 13.50%
Cost of debt 4.00% - 4.90% 4.45%
WACC 6.9% - 9.2% 8.0%
WACC

RGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.50%
Tax rate 11.30% 15.70%
Debt/Equity ratio 0.06 0.06
Cost of debt 4.00% 4.90%
After-tax WACC 6.9% 9.2%
Selected WACC 8.0%

RGEN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for RGEN:

cost_of_equity (8.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.7) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.